• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

ASOA names Giaimo as new executive director

Article

The board of directors of the American Society of Ophthalmic Administrators (ASOA) has appointed Eileen Giaimo, of Burke, VA, as its new executive director.

Related Videos
Related Content
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes

Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE

The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE

Article
EyePod: Modifier Gene Therapy: What is it?

EyePod: Modifier Gene Therapy: What is it?

Podcast
Verana Health launches its Qdata Thyroid Eye Disease module

Verana Health launches its Qdata Thyroid Eye Disease module

Article
Gene editing untangles one strand of the AMD web

Gene editing untangles one strand of the AMD web

Article
© 2024 MJH Life Sciences

All rights reserved.